Exome Asset Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Exome Asset Management’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-117,000	Closed	-$4.64M	–	79
2024 Q1	$4.64M	Sell	117,000 -56,500	-33%	-$1.67M	3.97%	5
2023 Q4	$3.31M	Buy	+173,500	New	+$2.41M	3.27%	8

Exome Asset Management's ALPN Position: Q2 2024 in Review

Exome Asset Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 117,000 shares — an estimated $4.64M sold.

Exome Asset Management first reported a position in ALPN in Q4 2023 and held it in 2 quarters. The position peaked at $4.64M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Exome Asset Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Exome Asset Management sold 117,000 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $4.64M.
Exome Asset Management first reported a position in Alpine Immune Sciences Inc in Q4 2023 and held it in 2 quarters.
Exome Asset Management's Alpine Immune Sciences Inc position peaked at $4.64M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Exome Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.